PedAM
Pediatric Disease Annotations & Medicines
| cardiac arrest | ||||
| Disease ID | 863 |
|---|---|
| Disease | cardiac arrest |
| Manually Symptom | (Waiting for update.) |
| Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
|---|
| (Waiting for update.) |
All Snps(Total Genotypes:16) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
| rs149767043 | 21683323 | 25943 | C20orf194 | umls:C0018790 | BeFree | The expansion showed complete segregation with the SCA phenotype in family studies, whereas Phe265Leu in C20orf194 did not. | 0.000271442 | 2011 | C20orf194 | 20 | 3343726 | G | C |
| rs16847548 | 19822806 | 9722 | NOS1AP | umls:C0018790 | BeFree | NOS1AP variants were significantly associated with the occurrence of symptoms (rs4657139, P=0.019; rs16847548, P=0.003), with clinical severity, as manifested by a greater probability for cardiac arrest and sudden death (rs4657139, P=0.028; rs16847548, P=0.014), and with greater likelihood of having a QT interval in the top 40% of values among all mutation carriers (rs4657139, P=0.03; rs16847548, P=0.03). | 0.000542884 | 2009 | NA | 1 | 162065484 | T | C |
| rs17779747 | 25819866 | 3759 | KCNJ2 | umls:C0018790 | BeFree | Three SNPs from 3 genes (rs17779747 [KCNJ2], rs876188 [C14orf64], rs3864180 [GPC5]) were significantly associated with SCD/CA in multivariable models (after correction for multiple testing); the minor allele of rs17779747 with a decreased risk (hazard ratio [HR] 0.68 per copy of the minor allele, 95% CI 0.50-0.92, P = .012), and rs876188 and rs386418 with an increased risk (HR 1.52 [95% CI 1.10-2.09, P = .011] and HR 1.34 [95% CI 1.04-1.82, P = .023], respectively). | 0.000542884 | 2014 | NA | 17 | 70498851 | G | T |
| rs17779747 | 25819866 | 2262 | GPC5 | umls:C0018790 | BeFree | Three SNPs from 3 genes (rs17779747 [KCNJ2], rs876188 [C14orf64], rs3864180 [GPC5]) were significantly associated with SCD/CA in multivariable models (after correction for multiple testing); the minor allele of rs17779747 with a decreased risk (hazard ratio [HR] 0.68 per copy of the minor allele, 95% CI 0.50-0.92, P = .012), and rs876188 and rs386418 with an increased risk (HR 1.52 [95% CI 1.10-2.09, P = .011] and HR 1.34 [95% CI 1.04-1.82, P = .023], respectively). | 0.000542884 | 2014 | NA | 17 | 70498851 | G | T |
| rs17779747 | 25819866 | 388011 | LINC01550 | umls:C0018790 | BeFree | Three SNPs from 3 genes (rs17779747 [KCNJ2], rs876188 [C14orf64], rs3864180 [GPC5]) were significantly associated with SCD/CA in multivariable models (after correction for multiple testing); the minor allele of rs17779747 with a decreased risk (hazard ratio [HR] 0.68 per copy of the minor allele, 95% CI 0.50-0.92, P = .012), and rs876188 and rs386418 with an increased risk (HR 1.52 [95% CI 1.10-2.09, P = .011] and HR 1.34 [95% CI 1.04-1.82, P = .023], respectively). | 0.000271442 | 2014 | NA | 17 | 70498851 | G | T |
| rs1805015 | 17600229 | 3566 | IL4R | umls:C0018790 | BeFree | The previously observed association with the IL4R 503 S/P variant and the novel association with the LTC4S(-444) A/C variant suggest that these loci may also contribute to large vessel stroke risk in children with SCA. | 0.000271442 | 2007 | IL4R | 16 | 27362859 | T | C |
| rs1805015 | 17600229 | 4056 | LTC4S | umls:C0018790 | BeFree | The previously observed association with the IL4R 503 S/P variant and the novel association with the LTC4S(-444) A/C variant suggest that these loci may also contribute to large vessel stroke risk in children with SCA. | 0.000271442 | 2007 | IL4R | 16 | 27362859 | T | C |
| rs1805128 | 20823649 | 3753 | KCNE1 | umls:C0018790 | BeFree | Aborted cardiac arrest in a patient carrying KCNE1 D85N variant during the postpartum period. | 0.000542884 | 2010 | KCNE1 | 21 | 34449382 | C | T |
| rs386418 | 25819866 | 2262 | GPC5 | umls:C0018790 | BeFree | Three SNPs from 3 genes (rs17779747 [KCNJ2], rs876188 [C14orf64], rs3864180 [GPC5]) were significantly associated with SCD/CA in multivariable models (after correction for multiple testing); the minor allele of rs17779747 with a decreased risk (hazard ratio [HR] 0.68 per copy of the minor allele, 95% CI 0.50-0.92, P = .012), and rs876188 and rs386418 with an increased risk (HR 1.52 [95% CI 1.10-2.09, P = .011] and HR 1.34 [95% CI 1.04-1.82, P = .023], respectively). | 0.000542884 | 2014 | NA | NA | NA | NA | NA |
| rs386418 | 25819866 | 3759 | KCNJ2 | umls:C0018790 | BeFree | Three SNPs from 3 genes (rs17779747 [KCNJ2], rs876188 [C14orf64], rs3864180 [GPC5]) were significantly associated with SCD/CA in multivariable models (after correction for multiple testing); the minor allele of rs17779747 with a decreased risk (hazard ratio [HR] 0.68 per copy of the minor allele, 95% CI 0.50-0.92, P = .012), and rs876188 and rs386418 with an increased risk (HR 1.52 [95% CI 1.10-2.09, P = .011] and HR 1.34 [95% CI 1.04-1.82, P = .023], respectively). | 0.000542884 | 2014 | NA | NA | NA | NA | NA |
| rs386418 | 25819866 | 388011 | LINC01550 | umls:C0018790 | BeFree | Three SNPs from 3 genes (rs17779747 [KCNJ2], rs876188 [C14orf64], rs3864180 [GPC5]) were significantly associated with SCD/CA in multivariable models (after correction for multiple testing); the minor allele of rs17779747 with a decreased risk (hazard ratio [HR] 0.68 per copy of the minor allele, 95% CI 0.50-0.92, P = .012), and rs876188 and rs386418 with an increased risk (HR 1.52 [95% CI 1.10-2.09, P = .011] and HR 1.34 [95% CI 1.04-1.82, P = .023], respectively). | 0.000271442 | 2014 | NA | NA | NA | NA | NA |
| rs4657139 | 19822806 | 9722 | NOS1AP | umls:C0018790 | BeFree | NOS1AP variants were significantly associated with the occurrence of symptoms (rs4657139, P=0.019; rs16847548, P=0.003), with clinical severity, as manifested by a greater probability for cardiac arrest and sudden death (rs4657139, P=0.028; rs16847548, P=0.014), and with greater likelihood of having a QT interval in the top 40% of values among all mutation carriers (rs4657139, P=0.03; rs16847548, P=0.03). | 0.000542884 | 2009 | NA | 1 | 162060117 | A | T |
| rs8007267 | 24136375 | 2643 | GCH1 | umls:C0018790 | BeFree | In vivo physiological studies of traits likely to be modulated by GCH1 showed rs8007267 is associated with altered endothelial dependent blood flow in females with SCA (8.42% of variation; P = 0.002). | 0.000271442 | 2013 | NA | 14 | 54912273 | C | T |
| rs876188 | 25819866 | 3759 | KCNJ2 | umls:C0018790 | BeFree | Three SNPs from 3 genes (rs17779747 [KCNJ2], rs876188 [C14orf64], rs3864180 [GPC5]) were significantly associated with SCD/CA in multivariable models (after correction for multiple testing); the minor allele of rs17779747 with a decreased risk (hazard ratio [HR] 0.68 per copy of the minor allele, 95% CI 0.50-0.92, P = .012), and rs876188 and rs386418 with an increased risk (HR 1.52 [95% CI 1.10-2.09, P = .011] and HR 1.34 [95% CI 1.04-1.82, P = .023], respectively). | 0.000542884 | 2014 | NA | 14 | 98012267 | G | A |
| rs876188 | 25819866 | 2262 | GPC5 | umls:C0018790 | BeFree | Three SNPs from 3 genes (rs17779747 [KCNJ2], rs876188 [C14orf64], rs3864180 [GPC5]) were significantly associated with SCD/CA in multivariable models (after correction for multiple testing); the minor allele of rs17779747 with a decreased risk (hazard ratio [HR] 0.68 per copy of the minor allele, 95% CI 0.50-0.92, P = .012), and rs876188 and rs386418 with an increased risk (HR 1.52 [95% CI 1.10-2.09, P = .011] and HR 1.34 [95% CI 1.04-1.82, P = .023], respectively). | 0.000542884 | 2014 | NA | 14 | 98012267 | G | A |
| rs876188 | 25819866 | 388011 | LINC01550 | umls:C0018790 | BeFree | Three SNPs from 3 genes (rs17779747 [KCNJ2], rs876188 [C14orf64], rs3864180 [GPC5]) were significantly associated with SCD/CA in multivariable models (after correction for multiple testing); the minor allele of rs17779747 with a decreased risk (hazard ratio [HR] 0.68 per copy of the minor allele, 95% CI 0.50-0.92, P = .012), and rs876188 and rs386418 with an increased risk (HR 1.52 [95% CI 1.10-2.09, P = .011] and HR 1.34 [95% CI 1.04-1.82, P = .023], respectively). | 0.000271442 | 2014 | NA | 14 | 98012267 | G | A |
GWASdb Annotation(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
GWASdb Snp Trait(Total Genotypes:20) | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CHR | POS | SNPID | REF | ALT | ORI_SNPID | PMID | P_VALUE | P_VALUE_TEXT | OR/BETA | CI95_TEXT | GWAS_INITIAL_SAMPLE_SIZE | SUB_POPULATION | SUPER_POPULATION | GWAS_TRAIT | HPO_ID | HPO_TERM | DO_ID | DO_TERM | MESH_ID | MESH_TERM | EFO_ID | EFO_TERM | DOLITE_TERM | RISK_ALLELE | PUBLICATION_TYPE | AA | GENE_SYMBOL | TYPE | REFGENE |
| 1 | 208128722 | rs2745967 | G | A | rs2745967 | 20639392 | 7.00E-08 | NA | 5.4 | [3.48-7.32] ms increase | 38,991 European ancestry individuals | European(38991) | ALL(38991) | EUR(38991) | ALL(38991) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs2745967-G | Research Support, Non-U.S. Gov't | G | NA |
| 5 | 179132612 | rs7735702 | T | A | rs7735702 | 24680774 | 2.16E-08 | NA | NA | NA | 855 Friuli Venezia Giulia individuals | Friuli Venezia Giulia(855) | ALL(855) | EUR(855) | ALL(855) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs7735702-T | NA | A | CANX |
| 5 | 179135815 | rs6893300 | C | A | rs6893300 | 24680774 | 9.00E-09 | NA | NA | NA | 855 Friuli Venezia Giulia individuals | Friuli Venezia Giulia(855) | ALL(855) | EUR(855) | ALL(855) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs6893300-C | NA | C | CANX |
| 5 | 179168097 | rs17617068 | T | C | rs17617068 | 24680774 | 1.00E-08 | NA | NA | NA | 855 Friuli Venezia Giulia individuals | Friuli Venezia Giulia(855) | ALL(855) | EUR(855) | ALL(855) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs17617068-T | NA | T | MAML1 |
| 5 | 179185121 | rs4700838 | A | G | rs4700838 | 24680774 | 1.21E-08 | NA | NA | NA | 855 Friuli Venezia Giulia individuals | Friuli Venezia Giulia(855) | ALL(855) | EUR(855) | ALL(855) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs4700838-A | NA | A | MAML1 |
| 5 | 179193598 | rs3797776 | C | T | rs3797776 | 24680774 | 2.09E-08 | NA | NA | NA | 855 Friuli Venezia Giulia individuals | Friuli Venezia Giulia(855) | ALL(855) | EUR(855) | ALL(855) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs3797776-C | NA | G | MAML1 |
| 5 | 179209059 | rs11738269 | C | A | rs11738269 | 24680774 | 1.87E-08 | NA | NA | NA | 855 Friuli Venezia Giulia individuals | Friuli Venezia Giulia(855) | ALL(855) | EUR(855) | ALL(855) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs11738269-C | NA | C | NA |
| 5 | 179214024 | rs1469020 | G | A | rs1469020 | 24680774 | 1.67E-08 | NA | NA | NA | 855 Friuli Venezia Giulia individuals | Friuli Venezia Giulia(855) | ALL(855) | EUR(855) | ALL(855) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs1469020-G | NA | G | NA |
| 5 | 179220638 | rs730012 | A | C | rs730012 | 24680774 | 1.66E-08 | NA | NA | NA | 855 Friuli Venezia Giulia individuals | Friuli Venezia Giulia(855) | ALL(855) | EUR(855) | ALL(855) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs730012-A | NA | A | LTC4S |
| 6 | 118574061 | rs281868 | G | A | rs281868 | 20639392 | 4.00E-10 | NA | 6.3 | [4.36-8.24] ms decrease | 38,991 European ancestry individuals | European(38991) | ALL(38991) | EUR(38991) | ALL(38991) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs281868-G | Research Support, Non-U.S. Gov't | C | SLC35F1 |
| 6 | 121748542 | rs11154022 | A | G | rs11154022 | 20639392 | 7.00E-08 | NA | 5.8 | [3.74-7.86] ms increase | 38,991 European ancestry individuals | European(38991) | ALL(38991) | EUR(38991) | ALL(38991) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs11154022-A | Research Support, Non-U.S. Gov't | G | NA |
| 6 | 122114451 | rs9320841 | A | G | rs9320841 | 23183192 | 5.00E-15 | Random effects analysis | 13 | [9.67-16.33] ms increase | 13,372 African American individuals | African American(13372) | ALL(13372) | AFR(13372) | ALL(13372) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | NA | Multicenter Study | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't |
| 6 | 122146034 | rs9398652 | C | A | rs9398652 | 20639392 | 4.00E-15 | NA | 12.6 | [9.54-15.66] ms decrease | 38,991 European ancestry individuals | European(38991) | ALL(38991) | EUR(38991) | ALL(38991) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs9398652-A | Research Support, Non-U.S. Gov't | A | NA |
| 7 | 100453208 | rs314370 | T | C | rs314370 | 20639392 | 6.00E-10 | NA | 7.6 | [5.23-9.97] ms decrease | 38,991 European ancestry individuals | European(38991) | ALL(38991) | EUR(38991) | ALL(38991) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs314370-C | Research Support, Non-U.S. Gov't | A | SLC12A9 |
| 7 | 100486754 | rs12666989 | G | C | rs12666989 | 20639392 | 2.00E-08 | NA | 7 | [4.63-9.37] ms decrease | 38,991 European ancestry individuals | European(38991) | ALL(38991) | EUR(38991) | ALL(38991) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs12666989-C | Research Support, Non-U.S. Gov't | G | UFSP1 |
| 11 | 61570783 | rs174547 | T | C | rs174547 | 20639392 | 2.00E-09 | NA | 6.2 | [4.22-8.18] ms decrease | 38,991 European ancestry individuals | European(38991) | ALL(38991) | EUR(38991) | ALL(38991) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs174547-C | Research Support, Non-U.S. Gov't | C | FADS1 |
| 12 | 24770878 | rs17287293 | A | G | rs17287293 | 20639392 | 2.00E-10 | NA | 8.6 | [6.03-11.17] ms increase | 38,991 European ancestry individuals | European(38991) | ALL(38991) | EUR(38991) | ALL(38991) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs17287293-G | Research Support, Non-U.S. Gov't | A | NA |
| 14 | 23865885 | rs452036 | G | A | rs452036 | 20639392 | 4.00E-14 | NA | 7.8 | [5.84-9.76] ms decrease | 38,991 European ancestry individuals | European(38991) | ALL(38991) | EUR(38991) | ALL(38991) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs452036-A | Research Support, Non-U.S. Gov't | A | MYH6 |
| 14 | 23865885 | rs452036 | G | A | rs452036 | 23183192 | 8.00E-07 | Fixed effects analysis | 9.6 | [5.68-13.52] ms increase | 13,372 African American individuals | African American(13372) | ALL(13372) | AFR(13372) | ALL(13372) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs452036-G | Multicenter Study | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't |
| 14 | 23977010 | rs223116 | A | G | rs223116 | 20639392 | 3.00E-08 | NA | 7.4 | [4.85-9.95] ms decrease | 38,991 European ancestry individuals | European(38991) | ALL(38991) | EUR(38991) | ALL(38991) | Resting heart rate | HPOID:0001695 | Cardiac arrest | DOID:10273 | heart conduction disease | D006339 | Heart Rate | EFOID:0004351 | resting heart rate | Cardiovascular disease | rs223116-A | Research Support, Non-U.S. Gov't | A | NA |
Mapped by lexical matching(Total Items:0) |
|---|
| (Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
|---|
| (Waiting for update.) |
Chemical(Total Drugs:63) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
| C0018790 | acetylcysteine | D000111 | 616-91-1 | heart arrest | MESH:D006323 | marker/mechanism | 1355236 | ||
| C0018790 | adenosine triphosphate | D000255 | 56-65-5 | heart arrest | MESH:D006323 | marker/mechanism | 11446933 | ||
| C0018790 | amitriptyline | D000639 | 50-48-6 | heart arrest | MESH:D006323 | marker/mechanism | 1145841 | ||
| C0018790 | atenolol | D001262 | 29122-68-7 | heart arrest | MESH:D006323 | marker/mechanism | 15304417 | ||
| C0018790 | atropine | D001285 | 51-55-8 | heart arrest | MESH:D006323 | marker/mechanism | 2699785 | ||
| C0018790 | atropine | D001285 | 51-55-8 | heart arrest | MESH:D006323 | therapeutic | 17907030 | ||
| C0018790 | azithromycin | D017963 | 83905-01-5 | heart arrest | MESH:D006323 | marker/mechanism | 11459586 | ||
| C0018790 | bupivacaine | D002045 | 2180-92-9 | heart arrest | MESH:D006323 | marker/mechanism | 10740180 | ||
| C0018790 | caffeine | D002110 | 1958/8/2 | heart arrest | MESH:D006323 | marker/mechanism | 19120009 | ||
| C0018790 | carbachol | D002217 | - | heart arrest | MESH:D006323 | marker/mechanism | 16740173 | ||
| C0018790 | carbamazepine | D002220 | 298-46-4 | heart arrest | MESH:D006323 | marker/mechanism | 6613526 | ||
| C0018790 | chloroquine | D002738 | 1954/5/7 | heart arrest | MESH:D006323 | marker/mechanism | 10941453 | ||
| C0018790 | chlorpromazine | D002746 | 50-53-3 | heart arrest | MESH:D006323 | marker/mechanism | 11673713 | ||
| C0018790 | cimetidine | D002927 | 51481-61-9 | heart arrest | MESH:D006323 | marker/mechanism | 6753681 | ||
| C0018790 | ciprofloxacin | D002939 | 85721-33-1 | heart arrest | MESH:D006323 | marker/mechanism | 15851230 | ||
| C0018790 | cisapride | D020117 | 81098-60-4 | heart arrest | MESH:D006323 | marker/mechanism | 10868744 | ||
| C0018790 | clonidine | D003000 | 4205-90-7 | heart arrest | MESH:D006323 | marker/mechanism | 17263743 | ||
| C0018790 | clonidine | D003000 | 4205-90-7 | heart arrest | MESH:D006323 | therapeutic | 15055893 | ||
| C0018790 | cyclophosphamide | D003520 | 50-18-0 | heart arrest | MESH:D006323 | marker/mechanism | 3332132 | ||
| C0018790 | digoxin | D004077 | 20830-75-5 | heart arrest | MESH:D006323 | marker/mechanism | 12921933 | ||
| C0018790 | diltiazem | D004110 | 42399-41-7 | heart arrest | MESH:D006323 | marker/mechanism | 12101159 | ||
| C0018790 | diltiazem | D004110 | 42399-41-7 | heart arrest | MESH:D006323 | therapeutic | 3245824 | ||
| C0018790 | disopyramide | D004206 | 3737/9/5 | heart arrest | MESH:D006323 | marker/mechanism | 7433320 | ||
| C0018790 | droperidol | D004329 | 548-73-2 | heart arrest | MESH:D006323 | marker/mechanism | 12460844 | ||
| C0018790 | enalapril | D004656 | 75847-73-3 | heart arrest | MESH:D006323 | marker/mechanism | 2849806 | ||
| C0018790 | enflurane | D004737 | 13838-16-9 | heart arrest | MESH:D006323 | marker/mechanism | 3605739 | ||
| C0018790 | epirubicin | D015251 | 56420-45-2 | heart arrest | MESH:D006323 | marker/mechanism | 3465877 | ||
| C0018790 | esmolol | C036604 | 84057-94-3 | heart arrest | MESH:D006323 | marker/mechanism | 8936932 | ||
| C0018790 | esmolol | C036604 | 84057-94-3 | heart arrest | MESH:D006323 | therapeutic | 7586280 | ||
| C0018790 | etomidate | D005045 | 33125-97-2 | heart arrest | MESH:D006323 | marker/mechanism | 6362477 | ||
| C0018790 | fluorouracil | D005472 | 51-21-8 | heart arrest | MESH:D006323 | marker/mechanism | 3245824 | ||
| C0018790 | glycopyrrolate | D006024 | 596-51-0 | heart arrest | MESH:D006323 | therapeutic | 9262685 | ||
| C0018790 | haloperidol | D006220 | 52-86-8 | heart arrest | MESH:D006323 | marker/mechanism | 19451589 | ||
| C0018790 | imipramine | D007099 | 50-49-7 | heart arrest | MESH:D006323 | marker/mechanism | 5552112 | ||
| C0018790 | isradipine | D017275 | 75695-93-1 | heart arrest | MESH:D006323 | marker/mechanism | 12066967 | ||
| C0018790 | labetalol | D007741 | 36894-69-6 | heart arrest | MESH:D006323 | marker/mechanism | 12456435 | ||
| C0018790 | lamotrigine | C047781 | 84057-84-1 | heart arrest | MESH:D006323 | marker/mechanism | 19845549 | ||
| C0018790 | lidocaine | D008012 | 137-58-6 | heart arrest | MESH:D006323 | marker/mechanism | 10195510 | ||
| C0018790 | lidocaine | D008012 | 137-58-6 | heart arrest | MESH:D006323 | therapeutic | 4039173 | ||
| C0018790 | liposomal amphotericin b | C068538 | - | heart arrest | MESH:D006323 | marker/mechanism | 19011270 | ||
| C0018790 | methadone | D008691 | 76-99-3 | heart arrest | MESH:D006323 | marker/mechanism | 15774410 | ||
| C0018790 | methylphenidate | D008774 | 113-45-1 | heart arrest | MESH:D006323 | marker/mechanism | 18957001 | ||
| C0018790 | mifepristone | D015735 | 84371-65-3 | heart arrest | MESH:D006323 | marker/mechanism | 1754984 | ||
| C0018790 | nicotine | D009538 | - | heart arrest | MESH:D006323 | marker/mechanism | 1259687 | ||
| C0018790 | norepinephrine | D009638 | 51-41-2 | heart arrest | MESH:D006323 | therapeutic | 19097734 | ||
| C0018790 | nortriptyline | D009661 | 72-69-5 | heart arrest | MESH:D006323 | marker/mechanism | 7352543 | ||
| C0018790 | paclitaxel | D017239 | - | heart arrest | MESH:D006323 | marker/mechanism | 15657205 | ||
| C0018790 | phentermine | D010645 | 122-09-8 | heart arrest | MESH:D006323 | marker/mechanism | 18606338 | ||
| C0018790 | phenylephrine | D010656 | 59-42-7 | heart arrest | MESH:D006323 | marker/mechanism | 12383833 | ||
| C0018790 | phenylephrine | D010656 | 59-42-7 | heart arrest | MESH:D006323 | therapeutic | 7586280 | ||
| C0018790 | phenylpropanolamine | D010665 | 14838-15-4 | heart arrest | MESH:D006323 | marker/mechanism | 3919189 | ||
| C0018790 | phenytoin | D010672 | 57-41-0 | heart arrest | MESH:D006323 | marker/mechanism | 11240605 | ||
| C0018790 | propranolol | D011433 | 525-66-6 | heart arrest | MESH:D006323 | marker/mechanism | 16987374 | ||
| C0018790 | reserpine | D012110 | 50-55-5 | heart arrest | MESH:D006323 | marker/mechanism | 39448 | ||
| C0018790 | ropivacaine | C037663 | 84057-95-4 | heart arrest | MESH:D006323 | marker/mechanism | 11524350 | ||
| C0018790 | sodium tetradecyl sulfate | D012981 | 1191-50-0 | heart arrest | MESH:D006323 | marker/mechanism | 8146856 | ||
| C0018790 | sotalol | D013015 | 3930-20-9 | heart arrest | MESH:D006323 | marker/mechanism | 17969573 | ||
| C0018790 | spironolactone | D013148 | 1952/1/7 | heart arrest | MESH:D006323 | marker/mechanism | 15912333 | ||
| C0018790 | succinylcholine | D013390 | 306-40-1 | heart arrest | MESH:D006323 | marker/mechanism | 10422386 | ||
| C0018790 | theophylline | D013806 | 58-55-9 | heart arrest | MESH:D006323 | therapeutic | 10628632 | ||
| C0018790 | thiopental | D013874 | 76-75-5 | heart arrest | MESH:D006323 | marker/mechanism | 2873831 | ||
| C0018790 | timolol | D013999 | 26839-75-8 | heart arrest | MESH:D006323 | marker/mechanism | 8378620 | ||
| C0018790 | vancomycin | D014640 | 1404-90-6 | heart arrest | MESH:D006323 | marker/mechanism | 12434613 | ||
FDA approved drug and dosage information(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |
FDA labeling changes(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |